Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs113063657 | chr13:114176846 | G/A | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs113137369 | chr17:74699440 | G/A | 0.00018 | 176 | 26.27 | 19.57 | 13.5 | KM Plot |
PCPG | rs113137542 | chr9:86649666 | T/A | 1.07E-5 | 173 | 26.22 | 23.83 | 10.3 | KM Plot |
PCPG | rs113146460 | chr7:1105164 | C/G | 0.000262 | 173 | 25.87 | 24.95 | 49.58 | KM Plot |
PCPG | rs113155017 | chr3:182617167 | C/G | 1.06E-5 | 174 | 25.87 | 27.2 | 11.78 | KM Plot |
PCPG | rs11316539 | chr3:136652552 | CT/C | 0.00021 | 172 | 17.6 | 27.23 | 23.83 | KM Plot |
PCPG | rs113174759 | chr16:1766459 | T/C | 0 | 173 | 25.6 | 15.85 | 2.93 | KM Plot |
PCPG | rs113221697 | chr7:1108743 | C/T | 0.000262 | 173 | 25.87 | 24.95 | 49.58 | KM Plot |
PCPG | rs113223941 | chr6:26538543 | C/A | 4.97E-7 | 177 | 25.08 | 29.57 | 10.68 | KM Plot |
PCPG | rs11327549 | chr22:21293695 | AT/A | 0.000101 | 174 | 12.93 | 31.2 | 24.62 | KM Plot |
PCPG | rs113343281 | chr22:50234552 | G/C | 0.000167 | 175 | 25.67 | 20.17 | 15.18 | KM Plot |
PCPG | rs113365567 | chr7:1108785 | T/C | 0.000262 | 173 | 25.87 | 24.95 | 49.58 | KM Plot |
PCPG | rs113375877 | chr3:176864354 | G/C | 8.27E-7 | 171 | 24.23 | 31.8 | 8.62 | KM Plot |
PCPG | rs113382723 | chr12:56691773 | AC/A | 9.45E-8 | 178 | 25.17 | 29.13 | 0.8 | KM Plot |
PCPG | rs11344584 | chr3:80551839 | CT/C | 1.27E-5 | 177 | 19.2 | 24.53 | 27.2 | KM Plot |